This study aims to investigate the effects of RT-90 resistant cassava starch on glycemic control using a human dietary trial and to evaluate its potential as a prebiotic fiber supplement. This study will assess the efficacy of RT-90 resistant cassava starch in improving glycemic control, body composition, and gut microbiome in healthy individuals.
Subjects aged 18-65 years.
Healthy subjects (BMI between 18.5-24.9 kg/m² for women and men).
Subjects must be able to maintain a stable diet (based on the Ministry of Health and Welfare's daily dietary guidelines, with a tolerance of ± 10-15%) and physical activity (based on the World Health Organization's recommendations of 150-300 minutes of moderate-intensity exercise per week, or equivalent physical activity, with a tolerance of ± 20%) during the trial period.
Subjects must understand the trial procedures and potential risks and benefits described in the consent form and be able to sign the consent form.
Pregnant or breastfeeding women.
Subjects with endocrine abnormalities, major organ disease, or mental illness (as determined by a physician).
Subjects found to be intolerant to the test sample during the trial.
Subjects who develop a disease or take medications or health supplements that could affect the results of the trial during the trial period. (e.g., hypoglycemic (lipid)-lowering medications, probiotics, high-dose dietary fiber supplements, fish oil, or supplements high in polyunsaturated fatty acids).